Abametapir
Back to searchMolecule Structure
Scientific Name
Abametapir
Description of the Drug
Abametapir is a pediculicide metalloproteinase used topically in the treatment of head lice infection.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11932
http://www.drugbank.ca/drugs/DB11932
Brand Name(s)
Xeglyze
Company Owner(s)
Hatchtech Pty Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Iron | METAL | SEQUESTERING AGENT | CHEMBL2363058 |
Copper | METAL | SEQUESTERING AGENT | CHEMBL2363057 |
Zinc | METAL | SEQUESTERING AGENT | CHEMBL2363056 |
Metalloproteinase | UNKNOWN | INHIBITOR | CHEMBL4495552 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL351152 |
Human Metabolome Database | HMDB0246854 |
DrugBank | DB11932 |
PubChem: Thomson Pharma | 15959449 |
PubChem | 15664 |
Mcule | MCULE-8581798506 |
Nikkaji | J23.945C |
PDBe | EI3 |
BindingDB | 50401351 |
EPA CompTox Dashboard | DTXSID00170095 |
DrugCentral | 5403 |
ChemicalBook | CB4764522 |
ChEBI | 192617 |
ZINC | ZINC000000403335 |